North Africa Generic Drug Market Share, Size, Growth, Opportunity and Forecast 2021-2026

*As the coronavirus disease (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

North Africa Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The North Africa Generic drug market is currently witnessing strong growth. A generic drug is a medication with the same active ingredients as a branded drug. It is identical in terms of quality, strength, dosage, performance, and efficiency. Moreover, it offers similar therapeutic effects at a substantially low cost. Therefore, its demand is escalating in the North African region.

The burgeoning pharmaceutical industry represents one of the major factors strengthening the growth of the generic drugs market in the North African region. Moreover, governing agencies are introducing price control policies and import restrictions to encourage domestic drug manufacturing in the region. This, in turn, is strengthening the growth of the generic drugs market. Other factors adding to the generic drug market growth are the rising prevalence of non-communicable diseases and increasing healthcare costs. However, the surging cases of coronavirus disease (COVID-19) and the imposition of lockdown restrictions across the region have disrupted the production of generic drugs. This has negatively affected the market, but it is anticipated to witness growth once lockdown restrictions are uplifted in the region and the production process acquires pace. Looking forward, the market is expected to continue its strong growth during the forecast period (2021-2026).

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the North Africa Generic drug market report, along with forecasts for growth at the region level from 2021-2026. Our report has categorized the market based on region, segment, therapy area, drug delivery and distribution channel.

Breakup by Segment:

Unbranded Generics
Branded Generics

Breakup by Therapy Area:

Central Nervous System
Cardiovascular
Dermatology
Genitourinary/Hormonal
Respiratory
Rheumatology
Diabetes
Oncology
Others

Breakup by Drug Delivery:

Oral
Injectables
Dermal/Topical
Inhalers

Breakup by Distribution Channel:

Retail Pharmacies
Hospital Pharmacies

Breakup by Country:

Algeria
Egypt
Libya
Morocco
Tunisia
Others

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Key Questions Answered in This Report:

How has the North Africa generic drug market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the North Africa generic drug market?
What are the key regional markets?
What is the breakup of the market based on the segment?
What is the breakup of the market based on the therapy area?
What is the breakup of the market based on the drug delivery?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the market?
What is the structure of the North Africa generic drug market and who are the key players?
What is the degree of competition in the market?